In recognition of Blood Cancer Awareness Month, Affimed’s CMO, Andreas Harstrick, discusses the firm’s methods for tackling blood cancers. Affimed focuses on harnessing the innate immune system, which is usually overlooked, and resulted in a 71% complete response rate in an exploratory study. The firm uses “natural killer” cells, part of our first line of immune defense.
Stop blaming maintainers for open source risks
Open source leaders are pushing for permanent government financing to maintain open source projects. They argue that as government oversight is vital to the national
